Skip to main content

Find Clinical Trials

Home
Conditions
Stage IIIB Breast Cancer

Clinical trial condition

Stage IIIB Breast Cancer

Explore clinical trials studying Stage IIIB Breast Cancer. Study availability and eligibility vary by location and protocol.

103 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Stage IIIB Breast Cancer trial results

Completed

Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy

NCT02002533

Conditions: Breast Diseases, Breast Neoplasms, Mental Disorders, +16 more
Locations: Stanford University Medical Center Stanford, California, United States

Heartland NCORP Decatur, Illinois, United States

Wichita NCORP Wichita, Kansas, United States

Metro-Minnesota NCORP Minneapolis, Minnesota, United States

View Trial Details

Completed

MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Breast Cancer After Chemotherapy Treatment

NCT02702830

Conditions: Breast Diseases, Breast Neoplasms, Healthy Subject, +11 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer

NCT01959490

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +7 more
Locations: University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Health Education Intervention in Reducing Weight Gain in Patients With Newly Diagnosed Stage I-IV Breast Cancer Undergoing Chemotherapy

NCT01941784

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +10 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

Akt Inhibitor MK2206 in Treating Patients With Advanced Breast Cancer

NCT01277757

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +7 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Columbia University/Herbert Irving Cancer Center New York, United States

Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment

NCT00425672

Conditions: Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +10 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Tipifarnib and Fulvestrant in Hormone Receptor-Positive Metastatic Breast Cancer

NCT00082810

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor-positive Breast Cancer, +8 more
Locations: Montefiore Medical Center The Bronx, New York, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer

NCT01632332

Conditions: Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +10 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery

NCT02219789

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor Positive, +9 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms

NCT01194440

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +19 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details